Form 8-K - Current report:
SEC Accession No. 0001193125-24-239650
Filing Date
2024-10-18
Accepted
2024-10-18 16:23:53
Documents
14
Period of Report
2024-10-18
Items
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d814860d8k.htm   iXBRL 8-K 27542
2 EX-4.1 d814860dex41.htm EX-4.1 73123
  Complete submission text file 0001193125-24-239650.txt   246605

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA tyra-20241018.xsd EX-101.SCH 2831
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE tyra-20241018_lab.xml EX-101.LAB 17980
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE tyra-20241018_pre.xml EX-101.PRE 11246
16 EXTRACTED XBRL INSTANCE DOCUMENT d814860d8k_htm.xml XML 3629
Mailing Address 2656 STATE STREET CARLSBAD CA 92008
Business Address 2656 STATE STREET CARLSBAD CA 92008 (619) 728-4760
Tyra Biosciences, Inc. (Filer) CIK: 0001863127 (see all company filings)

EIN.: 831476348 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40800 | Film No.: 241381022
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)